Viewing StudyNCT00031733



Ignite Creation Date: 2024-05-05 @ 11:25 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00031733
Status: COMPLETED
Last Update Posted: 2014-05-22
First Post: 2002-03-08

Brief Title: Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma
Sponsor: University of Southern California
Organization: University of Southern California

Organization Data

Organization: University of Southern California
Class: OTHER
Study ID: CDR0000069220 10M-01-1
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: University of Southern California
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH